Federal Register / Vol. 65, No. 234 / Tuesday, December 5, 2000 / Notices 75957

regular basis to ensure that the

company’s continued registration is

consistent with the public interest.

These investigations have included

inspection and testing of the company’s

physical security systems, audits of the

company’s records, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to 21 U.S.C. 823

and 28 CFR 0.100 and 0.104, the Deputy

Assistant Administrator, Office of

Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic classes of

controlled substances listed above is

granted.

Dated: November 20, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–30935 Filed 12–4–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances;

Notice of Registration

By notice dated August 14, 2000 and

published in the Federal Register on

August 23, 2000, (65 FR 51330),

Applied Science Labs, Inc., A Division

of Alltech Associates, Inc., 2701

Carolean Industrial Drive, P.O. Box 440,

State College, Pennsylvania 16801,

made application by renewal to the

Drug Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Heroine (9200) ............................. I

Cocaine (9041) ............................. II

Codeine (9050) ............................. II

Meperidine (9230) ........................ II

Methadone (9250) ........................ II

Morphine (9300) ........................... II

The firm plans to import these

controlled substances for the

manufacture of reference standards.

No comments or objections have been

received. DEA has considered the

factors in title 21, United States Code,

section 823(a) and determined that the

registration of Applied Science Labs,

Inc., to import the listed controlled

substances is consistent with the public

interest and with United States

obligations under international treaties,

conventions, or protocols in effect on

May 1, 1971, at this time. DEA has

investigated Applied Science Labs, Inc.,

on a regular basis to ensure that the

company’s continued registration is

consistent with the public interest.

These investigations have included

inspection and testing of the company’s

physical security systems, audits of the

company’s records, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to section 1008(a) of

the Controlled Substances Import and

Export Act and in accordance with title

21, Code of Federal Regulations,

§ 1301.34, the above firm is granted

registration as an importer of the basic

classes of controlled substances listed

above.

November 20, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–30938 Filed 12–4–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Registration

By notice dated August 8, 2000, and

published in the Federal Register on

August 23, 2000 (65 FR 51331),

Calbiochem-Novabiochem Corporation,

10394 Pacific Center Court, Attn:

Receiving Inspector, San Diego,

California 92121–4340, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Tetrahydrocannabinols (7370) ..... I

Mescaline (7381) .......................... I

Phencyclidine (7471) .................... II

Phenylaceton (8501) .................... II

Cocaine (9041) ............................. II

The firm plans to import small

quantities of the listed controlled

substances to make reagents for

distribution to the biomedical research

community.

No comments or objections have been

received. DEA has considered the

factors in title 21, United States Code,

section 823(a) and determined that the

registration of CalbiochemNovabiochem Corporation is consistent

with the public interest and with United

States obligations under international

treaties, conventions, or protocols in

effect on May 1, 1971, at this time. DEA

has investigated CalbiochemNovabiochem Corporation on a regular

basis to ensure that the company’s

continued registration is consistent with

the public interest. These investigations

have included inspection and testing of

the company’s physical security

systems, audits of the company’s

records, verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to section 1008(a) of the

Controlled Substance Import and Export

Act and in accordance with the Title 21,

Code of Federal Regulations, § 1301.34,

the above firm is granted registration as

an importer of the basic classes of

controlled substances listed above.

Dated: November 20, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Division Control, Drug Enforcement

Administration.

[FR Doc. 00–30939 Filed 12–4–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated June 29, 2000, and

published in the Federal Register on

July 14, 2000, (65 FR 43785), Cambridge

Isotope Lab, 50 Frontage Road, Andover,

Massachusetts 01810, made application

by renewal to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Methaqualone (2565) ................... I

Dimethyltryptamine (7435) ........... I

Amphetamine (1100) .................... II

Methamphetamine (1105) ............ II

Pentobarbital (2270) ..................... II

Secobarbital (2315) ...................... II

Phencyclidine (7471) .................... II

Phenylacetone (8501) .................. II

Cocaine (9041) ............................. II

Codeine (9050) ............................. II

Oxycodone (9143) ........................ II

Hydromorphone (9150) ................ II

Benzoylecgonine (9180) ............... II

Methadone (9250) ........................ II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

Morphine (9300) ........................... II

Fentanyl (9801) ............................ II

75958 Federal Register / Vol. 65, No. 234 / Tuesday, December 5, 2000 / Notices

The firm plans to manufacture small

quantities of the listed controlled

substances to produce isotope labeled

standards for drug analysis.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

section 823(a) and determined that the

registration of Cambridge Isotope Lab to

manufacture the listed controlled

substances is consistent with the public

interest at this time. DEA has

investigated Cambridge Isotope Lab on a

regular basis to ensure that its continued

registration is consistent with the public

interest. These investigations have

included inspection and testing of the

company’s physical security systems,

audits of the company’s records,

verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: November 20, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–30932 Filed 12–4–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated June 14, 2000, and

published in the Federal Register on

June 26, 2000, (65 FR 39430), Celgene

Corporation, 7 Powder Horn Drive,

Warren, New Jersey 07059, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

methylphenidate (1724), a basic class of

controlled substance listed in Schedule

II.

The firm plans to manufacture

methylphenidate for product research

and development.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

section 823(a) and determined that the

registration of Celgene Corporation to

manufacture methylphenidate is

consistent with the public interest at

this time. DEA has investigated the

Celgene Corporation on a regular basis

to ensure that the company’s continued

registration is consistent with the public

interest. These investigations have

included inspection and testing of the

company’s physical security systems,

audits of the company’s records,

verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated: October 10, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–30933 Filed 12–4–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By notice dated June 29, 2000, and

published in the Federal Register on

July 14, 2000, (65 FR 43785), Chattem

Chemicals, Inc., 3801 St. Elmo Avenue,

Building 18, Chattanooga, Tennessee

37409, made application by renewal to

the Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Amphetamine (1100) .................... II

Methamphetamine (1105) ............ II

No comments or objections have been

received. The firm plans to bulk

manufacture amphetamine and

methamphetamine to produce products

for distribution to its customers.

DEA has considered the factors in title

21, United States Code, section 823(a)

and determined that the registration of

Chattem Chemicals, Inc. to manufacture

the listed controlled substances is

consistent with the public interest at

this time. DEA has investigated Chattem

Chemicals, Inc. on a regular basis to

ensure that the company’s continued

registration is consistent with the public

interest. These investigations have

included inspection and testing of the

company’s physical security systems,

audits of the company’s records,

verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: November 20, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–30937 Filed 12–4–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

The Church of the Living Tree; Notice

of Withdrawal of Denial of Application

On November 4, 1999, the Deputy

Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration (DEA) issued an Order

to Show Cause proposing to deny The

Church of the Living Tree’s application

for registration as a manufacturer of the

controlled substance marijuana.

Effective August 18, 2000, the DEA

Administrator, in his final order

published in the Federal Register, 65 FR

50567, denied the application for

registration, noting that The Church of

the Living Tree had not responded to

the Order to Show Cause.

By letter dated August 11, 2000, a

representative of The Church of the

Living Tree advised that he had in fact

properly submitted a timely request for

hearing. Photocopies of a United States

Postal Service Receipt for Certified Mail

and Domestic Return Receipt indicating

delivery accompanied the letter.

Inasmuch as it appears that The

Church of the Living Tree timely

requested a hearing in this matter, the

final order should not have issued. The

Deputy Administrator of the Drug

Enforcement Administration therefore

orders that the final order published

August 18, 2000, at 65 Fed. Reg. 50567

be, and it hereby is, rescinded, and this

matter is hereby remanded to the Office

of Administrative Law Judges, Drug

Enforcement Administration, for further

appropriate proceedings. This order is

effective December 5, 2000.